Style | Citing Format |
---|---|
MLA | Shakeran Z, et al.. "Co-Delivery of Stat3 Sirna and Methotrexate in Breast Cancer Cells." Artificial Cells, Nanomedicine and Biotechnology, vol. 50, no. 1, 2022, pp. 29-39. |
APA | Shakeran Z, Varshosaz J, Keyhanfar M, Mohammadbeigi H, Rahimi K, Sutherland DS (2022). Co-Delivery of Stat3 Sirna and Methotrexate in Breast Cancer Cells. Artificial Cells, Nanomedicine and Biotechnology, 50(1), 29-39. |
Chicago | Shakeran Z, Varshosaz J, Keyhanfar M, Mohammadbeigi H, Rahimi K, Sutherland DS. "Co-Delivery of Stat3 Sirna and Methotrexate in Breast Cancer Cells." Artificial Cells, Nanomedicine and Biotechnology 50, no. 1 (2022): 29-39. |
Harvard | Shakeran Z et al. (2022) 'Co-Delivery of Stat3 Sirna and Methotrexate in Breast Cancer Cells', Artificial Cells, Nanomedicine and Biotechnology, 50(1), pp. 29-39. |
Vancouver | Shakeran Z, Varshosaz J, Keyhanfar M, Mohammadbeigi H, Rahimi K, Sutherland DS. Co-Delivery of Stat3 Sirna and Methotrexate in Breast Cancer Cells. Artificial Cells, Nanomedicine and Biotechnology. 2022;50(1):29-39. |
BibTex | @article{ author = {Shakeran Z and Varshosaz J and Keyhanfar M and Mohammadbeigi H and Rahimi K and Sutherland DS}, title = {Co-Delivery of Stat3 Sirna and Methotrexate in Breast Cancer Cells}, journal = {Artificial Cells, Nanomedicine and Biotechnology}, volume = {50}, number = {1}, pages = {29-39}, year = {2022} } |
RIS | TY - JOUR AU - Shakeran Z AU - Varshosaz J AU - Keyhanfar M AU - Mohammadbeigi H AU - Rahimi K AU - Sutherland DS TI - Co-Delivery of Stat3 Sirna and Methotrexate in Breast Cancer Cells JO - Artificial Cells, Nanomedicine and Biotechnology VL - 50 IS - 1 SP - 29 EP - 39 PY - 2022 ER - |